RecruitingNot ApplicableNCT04296604
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
Sponsor
Massachusetts General Hospital
Enrollment
600 participants
Start Date
Sep 1, 2014
Study Type
INTERVENTIONAL
Conditions
Summary
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria2
- Male and female outpatients 18-65 years of age
- A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
Exclusion Criteria6
- Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.
- Active substance dependence (except for tobacco and cannabis).
- Pregnant or nursing females.
- Inability to participate in testing procedures.
- Diagnosis of psychiatric of neurological disorder
- Ongoing treatment with any psychotropic medications.
Interventions
DEVICETranscranial Direct Current Stimulation
In tDCS, electrodes are applied on the scalp to transmit direct current at low current amplitudes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04296604
Related Trials
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT000180571 location
Tolerability of MDMA in Schizophrenia
NCT057703751 location
Smoking Cessation and Menstrual Cycle Phase
NCT055153541 location
rTMS for Depression in Young Adults With Autism
NCT049721361 location
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
NCT0719650145 locations